Ftse Mib
36.170,37
-0,13%
DAX
21.427,73
0,11%
S&P 500
5.994,57
-0,76%
NASDAQ
19.391,96
-1,20%
Bitcoin
98.787,29
-2,60%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Evogene Ltd (EVGN) Evogene Ltd (EVGN) Notizie

Evogene Ltd

EVGN
1,47
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/12/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/11/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202413:35EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/11/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202413:30PRNUSEvogene Reports Third Quarter 2024 Financial Results
19/11/202413:00PRNUSLavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy..
12/11/202413:00PRNUSLavie Bio Announces Commercial Expansion of Yalos® as..
07/11/202413:00PRNUSEvogene Schedules Third Quarter 2024 Financial Results..
31/10/202413:00PRNUSEvogene Announces Collaboration with Google Cloud to Pioneer..
29/10/202413:00PRNUSCasterra Announces a Key Milestone in its Operational..
15/10/202412:52EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
30/9/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/9/202413:00PRNUSLavie Bio Receives Grant from Israel Innovation Authority to..
30/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/9/202422:15EDGAR2Form F-1 - Registration statement for certain foreign..
17/9/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/8/202415:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202414:55PRNUSEvogene Announces Pricing of US$5.5 Million Registered..
23/8/202414:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/8/202413:00PRNUSEvogene Reports Second Quarter 2024 Financial Results
12/8/202413:11PRNUSEvogene Regains Compliance with Nasdaq Minimum Closing Bid..
12/8/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/8/202413:00PRNUSEvogene Schedules Second Quarter 2024 Financial Results..
31/7/202413:00PRNUSCasterra Announces the Completion of a Successful Castor..
23/7/202414:48PRNUSEvogene Announces Expected Implementation of 1-for-10..
23/7/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/7/202414:00PRNUSICL and Lavie Bio Leverage Artificial Intelligence to Make..
02/7/202413:00PRNUSLavie Bio Announces Commercial Expansion of Yalos™ to Winter..
25/6/202413:00PRNUSCasterra Announces an Additional Purchase Order to Supply..
17/6/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202422:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202417:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202417:00PRNUSBiomica Presents Positive Clinical Data Update from Ongoing..
23/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202413:00PRNUSEvogene Reports First Quarter 2024 Financial Results
21/5/202413:03PRNUSCasterra Announces Additional Agreements with Seed Producers..
09/5/202413:00PRNUSEvogene Schedules First Quarter 2024 Financial Results..
16/4/202413:00PRNUSBiomica to Present at the American Society of Clinical..
11/4/202413:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
02/4/202413:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
28/3/202414:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
20/3/202414:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
19/3/202414:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
13/3/202414:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
07/3/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202413:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
Apertura: Min: Max:
Chiusura: 1,47

La tua Cronologia

NASDAQ
EVGN
Evogene
TSXV
MYM
BIT
SUOE
Exchange Traded
BIT
RNRG
Exchange Traded Fund Glo...
TG
8Q7
Ordinary
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci